Federal Data Hub › HRSA 340B · JSON
340B ID CAH261318-00
ParticipatingCritical Access Hospital
SALEM MEMORIAL HOSPITAL is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in SALEM, MO. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 21 contract-pharmacy arrangement(s) (12 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| COUNTRY MART PHARMACY | SALEM, MO | 2013-04-01 | 2021-10-06 | 11048 |
| CVS CAREMARK | WILKES BARRE, PA | 2021-07-01 | — | 25050 |
| CVS CAREMARK ADVANCED TECHNOLOGY PHARMAC | MT PROSPECT, IL | 2021-07-01 | — | 59114 |
| MISSOURI CVS PHARMACY, L.L.C. | ROLLA, MO | 2021-07-01 | — | 90063 |
| MOSER PHARMACY | SALEM, MO | 2013-04-01 | — | 11046 |
| RINNE PHARMACY LLC | LICKING, MO | 2025-07-01 | — | 96289 |
| RINNE PHARMACY LLC | LICKING, MO | 2016-07-01 | 2017-06-16 | 96289 |
| SINKS PHARMACY | SALEM, MO | 2021-10-01 | 2022-08-31 | 130837 |
| SINKS PHARMACY | SALEM, MO | 2023-01-01 | — | 134866 |
| VANDIVORT DRUG | SALEM, MO | 2013-04-01 | 2021-02-23 | 11047 |
| VANDIVORT DRUG (WISDOM DRUG LLC) | SALEM, MO | 2021-01-01 | 2025-05-12 | 120485 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2017-04-01 | — | 70688 |
| WAL-MART PHARMACY 10-0027 | SALEM, MO | 2015-10-01 | — | 11043 |
| WAL-MART PHARMACY 10-0101 | ROLLA, MO | 2015-10-01 | 2017-06-16 | 11041 |
| WAL-MART PHARMACY 10-0101 | ROLLA, MO | 2025-07-01 | — | 11041 |
| WAL-MART PHARMACY 10-0166 | HOUSTON, MO | 2015-10-01 | 2023-08-03 | 11045 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2017-04-01 | — | 39270 |
| WALGREEN CO. | HOUSTON, MO | 2022-01-01 | 2022-01-01 | 109861 |
| WALGREEN CO. | ROLLA, MO | 2022-01-01 | 2022-01-01 | 62475 |
| WALMART PHARMACY 10-5169 | ROGERS, AR | 2026-07-01 | — | 66076 |
| Walmart Pharmacy 10-7611 | Plainfield, IN | 2026-07-01 | — | 140224 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.